First International Conference on High-Throughput Process Development
News May 05, 2010
GE Healthcare, a unit of General Electric Company, announces the start of a new conference series devoted to High-Throughput Process Development (HTPD). The first international conference will be held in Krakow, Poland on October 4-7, 2010. Leading experts will discuss the challenges and benefits of employing HTPD techniques in the development of production processes for biological products.
The conference opens with a plenary lecture “High-throughput techniques in a small-molecules world: Lessons learned”. Program sessions will cover the use of design of experiments and data mining to exploit HTPD; scale-up and scale-down studies; elimination of analytical challenges; and the future of HTPD. Industrial case studies that describe the use of high-throughput methods in process development activities will also be showcased. The conference will provide an excellent opportunity to discuss and influence the future of HTPD within the industry.
Scientists who are interested in contributing can submit oral and poster abstracts by May 1st, 2010. Research can be related to all aspects of high throughput process development, including new formats, new automation principles, further miniaturization, theoretical and practical considerations and analytical methods.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Synthetic Biology Breakthrough Means Bacteria Could Produce Our Essential DrugsNews
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles.READ MORE